This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Progestogen only pill (POP) and obesity

Authoring team

Progestogen-only pill (POP)

  • the available evidence suggests that effectiveness of the progestogen-only pill (POP) is not affected by body weight or BMI
  • the available evidence suggests that POP is a safe contraceptive option for women who are overweight and women with obesity

Weight gain with POP


In the general population there is no evidence suggesting a causal association between POP useand weight gain. There is no specific evidence relating to weight gain with POP use by women with raised BMI.

FSRH state (1):

  • double-dose POP for contraception is not recommended for women who are overweight or women with obesity

Reference:

  • FSRH (April 2019). Overweight, Obesity & Contraception

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.